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Anticipating missing reference standard data when planning 
diagnostic accuracy studies
Christiana A Naaktgeboren,1 Joris A H de Groot,1 Anne W S Rutjes,2,3 Patrick M M Bossuyt,4 
Johannes B Reitsma,1 Karel G M Moons1 
Results obtained using a reference 
standard may be missing for some 
participants in diagnostic accuracy 
studies. This paper looks at methods 
for dealing with such missing data 
when designing or conducting a 
prospective diagnostic accuracy study
The problem: missing reference standard data
Diagnostic studies typically evaluate the accuracy of 
one or more tests, markers, or models by comparing 
their results with those of, ideally, a “gold” reference 
test or standard.1 2  In such studies, the outcome—that 
is, the presence or absence of the target disease as 
determined by the chosen reference standard—is often 
missing in some of the study participants. This is known 
as partial verification.3 4  When only the participants 
who received the reference standard are included in the 
analysis (complete case analysis), estimates of the 
accuracy of the diagnostic test(s), marker(s), or mod-
el(s) under study, such as the sensitivity, specificity, 
predictive values, likelihood ratios, or C index, can be 
biased.5-8
There are many reasons why missing reference stan-
dard results may occur in diagnostic studies, as well as 
various approaches to deal with these missing out-
comes in the statistical analysis.3 4 8-16 Ideally, how miss-
ing outcome data will eventually be dealt with is 
determined during the design phase of the study as 
opposed to later during the data analysis phase.
Here, we build on previous research on methods for 
dealing with missing outcomes during the data analysis 
phase to look at specific measures that can be taken 
when designing or conducting a diagnostic accuracy 
study. This paper focuses on prospective studies in 
which all included patients suspected of having the dis-
ease of interest receive all tests under study as well as 
the reference standard. It does not cover alternative 
designs, such as separate sampling of diseased partici-
pants and healthy controls, or retrospective studies in 
which patients who have received both the index test 
and reference standard are identified in hospital data-
bases.17 Firstly, we discuss the various reasons for miss-
ing reference standard results, then we consider the 
proposed solutions to handle patterns of missing data, 
and we end with an overview of specific measures that 
can be considered in the design phase of a prospective 
diagnostic study to improve the proposed solutions.
How the problem arises
In clinical practice, the diagnostic process begins when 
signs, symptoms, or test results signal a possible target 
disease. Patients go through a diagnostic pathway, typ-
ically starting with inexpensive, non-invasive tests to 
rule out the presence of the disease.18 For those in 
whom the presence of the disease is still suspected, 
additional tests may follow that are increasingly costly, 
burdensome, and even risky. For safety and efficiency, 
not all patients originally suspected of having a disease 
eventually go on to receive the complete battery of tests.
In prospective diagnostic studies—that is studies that 
do not use routine care data such as hospital or primary 
care records—all study participants ideally receive all 
tests, markers, or models under study (from now on 
referred to as index tests) and then the reference stan-
dard to assign their final diagnosis. Nevertheless, even 
in predesigned prospective studies, missing outcomes 
on the reference standard are likely to occur and in 
some situations may even be unavoidable. These miss-
ing outcomes may occur haphazardly, in a more or less 
predictable way, or even by design (see table 1  for 
examples). As in any clinical study, haphazardly miss-
ing data may result from, for example, lost blood sam-
ples, technical failures, or accidental deviations from 
the study protocol. For example, in a study on the accu-
racy of rapid diagnostic tests for malaria, a few blood 
samples were lost before they could be examined under 
the microscope.19 We refer to this as “incidental missing 
data.” Although this type of missing data leads to a loss 
of precision, it does not necessarily lead to biased esti-
mates of test accuracy owing to the complete random-
ness of the missing outcomes.
Commonly, though, clear reasons exist why some 
participants in a study do not undergo the reference 
standard. It may be specified in the protocol of a pro-
spective accuracy study, for instance, that to reduce 
Summary poinTS
Missing reference standard results—that is, missing data on the target disease 
status—are common in diagnostic accuracy studies
Analyses that include only the study participants for whom the target disease 
status is actually measured may produce biased estimates of accuracy
Several statistical methods to reduce this bias are available; however, they all rely 
on assumptions about the pattern of missing outcomes, which are sometimes 
unverifiable
This paper provides an overview of the different patterns of missing data on the 
reference standard, the recommended corresponding solutions, and the specific 
measures that can be taken before and during a prospective diagnostic study to 
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study costs or burden to patients only a randomly 
selected subset of patients in a specific subgroup are to 
be verified by the preferred reference standard. We refer 
to this pattern as “data missing by study design”).20  For 
example, in a study on the diagnostic accuracy of visual 
inspection with acetic acid for detecting cervical can-
cer, in which the reference standard was colposcopy 
with biopsy, only a random subset of participants in 
whom no abnormalities were seen during visual inspec-
tion underwent colposcopy with a series of randomly 
located biopsies.21
In many diagnostic studies, the intention is to per-
form the reference standard in all patients, but for a 
variety of reasons missing outcomes occur. Typically, 
this is not a completely random process. Missingness 
may depend on several factors, such as severity of 
symptoms and other preceding test results, resulting in 
complicated patterns of missing outcomes that are also 
related to the results of index test. We refer to this pat-
tern as “data missing due to clinical practice.” Selective 
missing data are likely to cause biased estimates of 
accuracy of the index test in a complete case analysis. 
An example is a study on the diagnostic accuracy of fae-
cal calprotectin for irritable bowel disease; endoscopy 
combined with biopsy, the invasive reference standard, 
was limited to patients at high risk, defined as those 
with at least one predefined red flag symptom.22
In some clinical scenarios, it may be technically 
impossible to perform the reference standard in a well 
defined subgroup of participants. We refer to this as 
“data missing due to infeasibility.” This is common in 
cancer screening studies in which the reference stan-
dard is invasive. A specific example is a study on the 
diagnostic accuracy of ultrasonography for detecting 
breast cancer, in which one could not do a biopsy when 
no lesion was observed.23
How to deal with missing reference standard results
Understanding why missing outcomes occur is neces-
sary for judging whether estimates of diagnostic 
 accuracy are at risk of being biased, as well as whether 
and how this bias can be corrected for (table 2 ). In addi-
tion to keeping careful track of the reasons for missing 
reference standards, analytical methods are available 
to help to distinguish between “incidental missing 
data” and “data missing due to clinical practice.” 
A method commonly used to identify the risk of bias 
due to missing data is to compare the distribution of the 
patients’ characteristics and results of the index test(s) 
among the study participants with and without a miss-
ing outcome.24 If differences exist, the estimates based 
only on the participants with observed reference stan-
dard results (complete case analysis) are assumed to be 
at risk of bias, as those participants are not a completely 
random subset of the initial study population. Another 
method to judge the potential for bias is to do a sensitiv-
ity analysis to explore whether the range of values for 
the accuracy estimates of the index test are consistent 
with the data. Such a sensitivity analysis quantifies the 
possible range of sensitivities, specificities, predictive 
values, or C indices if all participants with a missing 
outcome were considered as either diseased or non-dis-
eased. A web tool has been developed that plots a 
so-called test ignorance region (available at uwmsk.
org/gsa).25 If the accuracy of the index test(s) from the 
complete case analysis falls outside this test ignorance 
Table 1 | Examples of different mechanisms for missing outcomes in diagnostic accuracy studies








Malaria Rapid diagnostic 
test
Microscopy Blood samples were lost, so data are probably missing completely at random
Data missing by study 
design21




Screening large population is expensive, and reference test is burdensome, so to 
reduce study costs and burden to patients only a random sample of those with 
normal screening tests received reference standard




Faecal calprotectin Endoscopy with 
biopsy
Endoscopy with biopsy is invasive, so it was applied only to patients at high risk 
(those with at least one “red flag” symptom)
Data missing due to 
infeasibility23
Breast cancer Ultrasonography Biopsy Biopsy is impossible to perform when no lesion is detected during mammography, 
so it was only done in participants with abnormal ultrasound results
Table 2 | Analytical approaches to reduce bias in estimated accuracy of diagnostic test(s), marker(s), or model(s) under study, introduced when 
preferred reference standard is not performed (that is, outcome is missing) in some study participants
Method Description
Sensitivity analysis25 Quantify possible range of accuracy if participants with missing preferred reference standard result were classified as either 
diseased or non-diseased
Complete case analysis Include only participants in whom preferred reference standard is performed in analysis
Inverse probability weighting (“Begg and 
Greenes method”)1126
Inflates number of participants by multiplying each cell or category (in which not all participants underwent preferred reference 
standard) by inverse probability of having outcome verified
Multiple imputation1516 Multiple complete datasets are created by using available data to predict plausible values for missing outcomes. Analyses are 
performed on these imputed datasets, and accuracy estimates of diagnostic index test(s), marker(s), or model(s) are pooled
Differential verification32 Perform a different (usually less accurate) reference standard in participants in whom preferred reference standard is missing. 
Subsequently, one may use one or both of following options:
Report results separately by reference 
standard used32
When index test, marker, or model results determine which subsequent test is used to verify outcome and outcome of alternative 
reference standard is clinically interpretable
Bayesian correction method for differential 
verification14
Such analysis adjusts accuracy estimates of index tests, on basis of assumptions about accuracy of reference standards used 
and verification pattern
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region, the assumption that the data are missing hap-
hazardly (completely at random) is not reasonable, so 
accuracy estimates are likely to be biased and should 
therefore be adjusted.
When outcomes are missing haphazardly (the pat-
tern “incidental missing data”)—that is, unrelated to 
any observed or unobserved patients’ characteristics or 
test results—and the study is large enough, a complete 
case analysis that includes only participants who 
underwent the reference standard will produce esti-
mates similar to those obtained if all original study par-
ticipants had been included, except that these accuracy 
estimates will be less precise. In that case, participants 
with the outcome can be seen as a completely random 
sample of the original study group, still representing a 
random sample from the study population defined by 
the eligibility criteria.
When outcomes are missing selectively (as is the case 
for all patterns except “incidental missing data”), a 
complete case analysis will probably produce biased 
estimates of accuracy. Analytical approaches for reduc-
ing the bias introduced by missing outcomes essentially 
use the available data to reconstruct the missing 
 outcome (see table 2  for an overview of these 
 methods).11 14-16 26 These methods either require knowl-
edge of or make assumptions about the pattern of the 
missing outcomes.
A straightforward correction method was developed 
by Begg and Greenes, who used inverse probability 
weighting, a technique also often used in causal 
research.11  Their approach can provide unbiased accu-
racy estimates of the index test(s) when the missing-
ness is actually random given the result of the index 
test(s). For a dichotomous index test, this method is 
equivalent to inflating the two-by-two table by 
 multiplying each cell by the inverse probability of hav-
ing undergone the reference standard. The assumption 
then is that patients with a negative (or positive) index 
test result who have not been verified would have 
shown comparable results to those with a negative (or 
positive) index test result who were verified. This 
method can be extended to incorporate additional fac-
tors that may have led to the missing outcomes. How-
ever, when the mechanism of the missing outcome data 
is not so straightforward and is based on multiple vari-
ables rather than only the index test(s), a more 
advanced method of reconstructing the data, such as 
multiple imputation, may be recommended instead.15 27
Imputation is the substitution of missing data with 
plausible values to allow for analysis of the entire data-
set. Multiple imputation is a statistical procedure that 
uses all available patients’ data to predict the missing 
data, in this case the missing outcome.28  These missing 
data are predicted multiple times, resulting in several 
complete datasets, often 10 or more, on which standard 
analyses are then performed.29  The accuracy estimates 
of the index tests from these datasets are then averaged 
to provide an overall estimate, with adjusted confi-
dence intervals that reflect the uncertainty resulting 
from the missing data. The more accurately the avail-
able data predict the missing outcomes, the less biased 
and more precise the accuracy estimates after multiple 
imputation will be. Even if some of the variables that 
influenced missingness are not available in the data, 
multiple imputation will probably still result in less 
biased results of the accuracy of the index tests than 
will complete case analysis.30  The challenge to multiple 
imputation is that it depends on the ability of additional 
patients’ data to accurately predict the missing refer-
ence standard results. Other, less straightforward, ana-
lytical methods for complex missing patterns exist, for 
which we refer to an overview of the literature.12
Instead of approaching the bias introduced by miss-
ing outcomes by using purely analytical correction 
methods, an alternative approach is to rely on results 
from a second reference standard to determine the out-
come in participants missing the preferred reference 
standard. The use of different reference standards in 
different participants is known as differential verifica-
tion.3 9 31 32  If the alternative reference standard classi-
fies disease status with less accuracy than does the 
preferred standard, this approach essentially results in 
misclassification of the outcome.33  As such, it may 
increase, rather than reduce, the bias in the estimated 
accuracy of the index test(s). When differential verifica-
tion is present, one might consider using an empirical 
bayesian correction method that takes into account the 
verification pattern as well as bias due to imperfections 
in the reference standards.14  This model requires speci-
fication of the pattern by which participants receive one 
reference standard or the other. It allows the research-
ers to incorporate their beliefs about the accuracy of the 
reference standards with respect to the true disease of 
interest in the form of previous distributions. Chal-
lenges to the bayesian correction method are under-
standing and specifying a potentially complex 
verification pattern and the availability of evidence on 
which to base beliefs about the accuracy of the refer-
ence standard. In the particular situation in which the 
type of reference standard a participant receives is com-
pletely dependent on the result of the index test, 
marker, or model, the predictive values are clinically 
interpretable. This would happen, for example, if all 
participants whose (dichotomous) index test result is 
abnormal receive the preferred reference standard and 
all others receive an alternative. In that case, one may 
simply choose to report results stratified by the index 
test results—that is, predictive values.32
Considerations for study design, analysis, reporting, and 
interpretation of results
Obviously, missing outcomes in diagnostic accuracy 
studies should ideally be avoided, as in any clinical 
study. All solutions for correcting bias introduced by 
missing outcomes are suboptimal. However, we argue 
that when missing outcomes are anticipated before the 
start of a diagnostic study, timely actions can be 
planned to optimise the validity of the study results. 
The protocols of prospective diagnostic accuracy stud-
ies can be enhanced by including information on the 
expected pattern of missing outcomes, as well as the 
chosen design and analytical solutions for reducing 
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the impact of these missing outcomes. In addition to 
presenting results that have been adjusted for missing 
outcomes, transparent reporting of the pattern of miss-
ing outcomes is important; this can be represented in a 
flowchart as recommended in the STARD guidelines.34 
Such reporting facilitates readers’ judgment of the risk 
of bias introduced by the missing outcomes and the 
appropriateness of the analytical solutions used to cor-
rect for this bias.
Table 3  contains an overview of the patterns for miss-
ing outcomes and the relation of these patterns to pos-
sible design, analytical, and reporting considerations. 
The appendix contains a worked out example for each 
of these patterns, using the clinical examples in table 1 
as inspiration.
Incidental missing data
A small amount of completely random missing data is 
almost inevitable in any study for reasons unrelated to 
any patients’ characteristics or index test results, such 
as data entry errors or dropping a blood sample. In an 
adequately sized study, excluding from the analysis 
participants for whom the reference standard result is 
missing completely at random will not bias the results—
it will only decrease precision. The percentage of miss-
ing outcomes should be reported, as well as the 
distribution of patients’ characteristics and index 
test  results among those without and with missing 
 outcomes, to allow the reader to judge whether they 
were missing completely at random and their exclusion 
thus would not lead to bias.34 Additionally, a sensitivity 
analysis as described above may provide further insight 
into the potential impact of the missing outcomes.
Data missing by study design
For efficiency, technical, or ethical reasons, it may be 
desirable not to perform the reference standard by 
design in all participants but only in a random sample 
of, for example, those with “normal” index test results 
and to adjust for this partial verification in the analysis 
(“data missing by study design”). This may be an effi-
cient approach in situations in which the prevalence of 
disease is low—for instance, in screening. Unfortu-
nately, no a priori sample size calculations are available 
to determine how large such random samples need to 
be. One must ensure that the random sample that will 
be verified by the reference standard will contain a suf-
ficient number of participants with and without the tar-
get condition.35 Therefore, researchers choosing such a 
design should provide a rationale for the number and 
type of participants who will randomly be verified in 
specific subgroups.
Data missing due to clinical practice
When the outcome is missing more often in participants 
with specific characteristics or index test results, such 
Table 3 | Anticipating missing results on best available or preferred reference standard (missing outcomes): considerations for design, conduct, 
analysis, reporting, and interpretation
Characteristic Incidental missing data Data missing by research design Data missing due to clinical practice Data missing due to infeasibility
Description Missingness likely to be 
completely random
Planned verification in only random 
sample of pre-specified subgroup(s) of 
patients
Missingness more likely to occur in 
certain patients
Preferred reference standard not 





accidental loss of blood 
samples
Costs or logistics hinder performing 
reference standard in all patients
Patient/physician’s decision not to 
perform preferred reference standard (for 
example, in patients with low probability 
of target disease)
Technically/ethically impossible 
to perform reference standard in 
certain patients (for example, 




Complete case analysis 
may suffice
A: Inverse probability weighting may 
suffice (reweight patients in random 
sample on basis of sampling fraction).
A: Multiple imputation (impute missing 
reference standard result)
Perform alternative reference 
standard in non-verified patients 
(differential verification) and 
report results per reference 
standard
B: Multiple imputation of missing 
reference standard result may also be 
used if other factors may also have 
influenced eventual decision to perform 
reference standard
B: Bayesian correction method for 
differential verification (perform 
secondary reference standard in 
non-verified patients and adjust for its 
imperfection)
Design and conduct
General Take measures to prevent missing results on preferred reference standard and, if applicable, on any other reference standard used. Document 
reasons for missing results on preferred and, if applicable, any other reference standard used
Specific
–
Consider number of patients in subgroup 
that will be verified
A: Perform additional tests and record 
additional information to improve 
imputation.
–
B: Apply secondary reference standard 
and obtain and incorporate external data 
on its imperfection
Analysis, reporting, and interpretation
General Report reasons for missing results on preferred reference standard and, if applicable, on any other reference standard used. Report flow of patients 
through study according to STARD guidelines flowchart. Consider sensitivity analysis
Specific
–
Provide rationale for subgroup and 
number of patients in subgroup that will 
be verified –
Provide rationale for chosen 
alternative reference standard 
and discuss its clinical meaning. 
Report accuracy results of index 
test(s) stratified by type of 
reference standard used
*See table 2 for details of these analytical approaches.
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as those with less severe symptoms or normal index test 
results, a complete case analysis will probably result in 
biased estimates of the accuracy of the index test. 
Whether this is the case can be inferred from a compar-
ison of the distributions in participants with and with-
out missing outcomes. If investigators plan to use an 
analytical method to correct for this bias, such as 
inverse probability weighting or multiple imputation, 
they should take appropriate actions for collecting 
additional information on study participants, such as 
signs, symptoms, and perhaps even additional test 
results, that will improve the performance of these 
methods. When the pattern by which patients receive 
one or another reference standard is more complex, as 
is often the case, multiple imputation is preferable to 
inverse probability weighting, as it makes accounting 
for more than one factor easier.
Sometimes a secondary reference standard—that is, a 
test that provides information about the outcome—is 
available but is less accurate than the preferred reference 
standard. Instead of using analytical correction methods 
to correct for partial verification bias, one can use this sec-
ondary reference standard to assess the outcome in par-
ticipants who did not receive the preferred reference 
standard. A bayesian correction method can then be used 
to calculate the proper index test accuracy estimates.14 
Here, it is important to report the assumptions made, 
such as the accuracy of the secondary reference standard 
with respect to the preferred reference standard. We stress 
that all of these methods to correct for bias due to “data 
missing due to clinical practice” assume that the pattern 
of missing reference standard results either is known or 
can be predicted by observed information.
Data missing due to infeasibility
When performing the reference standard in any of the 
participants in specific subgroups is explicitly decided 
against or even impossible—for example, no biopsy of 
the breast in women without any abnormality on mam-
mography (table 1 )—some alternative measure of the 
target disease should be obtained. In the design phase 
of a study, the decision can be made to use an alterna-
tive reference standard in these participants, a common 
choice being clinical follow-up. Rather than focusing 
on how well the index test results correspond to the pre-
ferred reference standard, it may be more relevant to 
focus on whether the index test provides information 
about clinically relevant outcomes. If so, the clinical 
relevance of this alternative reference standard should 
be discussed. One should then focus on the accuracy 
estimates of the index tests across strata of the index 
test results—that is, presenting predictive values.3 32
Considerations for study design
Although we have provided guidance for how to handle 
missing data on the reference standard, we stress that 
situations exist in which these approaches to deal with 
missing reference standard data may not be possible or 
cannot remove the bias, even when researchers antici-
pate the missing reference standards before the study 
starts. Additionally, although unbiased estimates of 
diagnostic test accuracy help to evaluate potential clin-
ical value, cross sectional accuracy studies do not 
always provide the information needed when forming a 
conclusion about whether a test improves the care of 
patients. Hence, in some situations, it may be necessary 
to go beyond accuracy studies and opt for alternative 
designs that focus on estimating or comparing the clin-
ical value of tests in terms of their ability to improve 
actual outcomes for patients.36-40 This may often be the 
case when missing outcomes are unavoidable or the 
new index test is hypothesised to outperform the refer-
ence standard.
Conclusion
Despite efforts to assess the outcome in all participants 
in a diagnostic accuracy study, missing reference stan-
dard results (that is, missing outcomes) are often inevi-
table and should be anticipated in any prospective 
diagnostic accuracy study. Analyses that include only 
the participants in whom the reference standard was 
performed are likely to produce biased estimates of the 
accuracy of the index tests. Several analytical solutions 
for dealing with missing outcomes are available; how-
ever, these solutions require knowledge about the pat-
tern of missing data, and they are no substitute for 
complete data. Researchers should anticipate the 
mechanisms that generate missing reference standard 
results before the start of a study, so that measures and 
actions can explicitly be taken to reduce the potential 
for biased estimates of the accuracy of the tests, mark-
ers, or models under study, as well as to facilitate cor-
rection in the analysis phase. In all cases, researchers 
should include in their study report how missing data 
on the index test and reference standard were handled, 
as invited by the STARD reporting guideline.34
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